‘Research centre’: Nobel laureate praises UAE healthcare system for cancer patients – News

Nobel laureate James Allison, whose pioneering work has revolutionized cancer immunotherapy, expressed optimism in the UAE healthcare system about offering new treatments.

“We are impressed with the infrastructure that is being built here in Abu Dhabi and the United Arab Emirates in terms of the health system, especially in terms of obtaining patient data for the development of drugs and new cancer treatments, such as immunotherapy and personalized genomic medicine therapies,” Professor Allison said during the 20224 edition of the Worldwide Innovative Network (WIN) symposium held outside Europe for the first time.

“We believe that cancer can be cured with the right combination of strategies, including immunotherapy. Abu Dhabi and the infrastructure here will definitely lead to some good things for cancer patients. The efforts being made to increase patient participation in clinical trials are impressive and this will very quickly make it a hub for biomedical research and drug development,” said Professor Allison, winner of the 2018 Nobel Prize in Medicine. . Khaleej Times.

Stay up to date with the latest news. Follow KT on WhatsApp channels.

He is known for his fundamental discoveries in T cell biology that launched the field of cancer immunotherapy.

James Allison with his wife, Professor Padmanee Sharma

Marking a collaboration between the WIN Consortium and Abu Dhabi-based Burjeel Holdings, the two-day annual global congress brings together more than 500 clinicians, researchers and scientists in the field from 30 countries to explore the latest advances in precision oncology, to improve cancer patient care and outcomes worldwide.

Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, highlighted the Group’s commitment to cancer care.

“We are committed to improving our understanding of cancer and working to improve patient care, not only for current but also future generations in the UAE and the region. The only way to achieve this is by fostering an engaging dialogue between international academics and innovators and local experts to bridge theory and real-world practice and forge lasting partnerships,” said Dr Shamsheer.

Take a collaborative approach

Professor Allison, Regental Professor and Chair of the Department of Immunology at MD Anderson Cancer Center (USA), highlighted the importance of international collaboration in the fight against cancer.

“It’s wonderful to see the spread of these conferences outside of the United States and Europe and to see knowledge and ideas flowing freely between all of these groups. This is important to expand care to more patients and advance science to cure more patients. “Different types of cancer are prevalent in different countries and we must all work together if we want to beat the disease.”

Professor Allison’s journey in cancer research began with a deeply personal experience. His mother died of lymphoma when he was about 10, and shortly afterward, two of his siblings died of cancer. This motivated him to pursue a career in immunology and ultimately led to her groundbreaking research on T cells and their role in the immune system’s ability to detect and eliminate cancer cells. Her work led to the development of the first immune checkpoint inhibitor drug to treat cancer for which she later won the Nobel Prize.

[ad_2]